{"id":"W1966245088","doi":"10.1097/qad.0b013e32835f1db0","title":"Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy","year":2013,"lang":"en","type":"review","venue":"AIDS","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"International AIDS Society","keywords":"Nevirapine; Efavirenz; Medicine; Antiretroviral therapy; Virology; Adverse effect; Reverse-transcriptase inhibitor; Human immunodeficiency virus (HIV); Sida; Viral disease; Viral load; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002055192,0.0006911164,0.00202169,0.0002961243,0.0001168715,0.00001324672,0.0001234463,0.0003375381,0.0002683149],"category_scores_gemma":[0.00006429206,0.0004119363,0.0003238049,0.0004981959,0.0000939036,0.00008813646,0.00004012521,0.0003442643,0.0002000681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002109411,"about_ca_system_score_gemma":0.0003865667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002582375,"about_ca_topic_score_gemma":0.00000589847,"domain_scores_codex":[0.997979,0.0001229535,0.0005304356,0.0005454522,0.0004044233,0.0004177712],"domain_scores_gemma":[0.9987593,0.0001667502,0.0003391319,0.0004206179,0.00009634476,0.000217911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007070465,0.0005492084,0.02046677,0.002241433,0.001976472,0.0001515281,0.00004370023,1.837384e-7,4.228642e-7,0.000009324856,0.0009701217,0.9735202],"study_design_scores_gemma":[0.006939903,0.002345697,0.001746097,0.01815343,0.002449102,0.00003256667,0.000006978124,0.00001771347,0.000005812737,0.000006024931,0.9676874,0.0006092219],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006126093,0.9909614,0.0000173788,0.0001768646,0.000108798,0.002082639,0.00004869958,0.0001313882,0.0003467064],"genre_scores_gemma":[0.001594929,0.9805858,0.0007856833,0.0001475422,0.0001003772,0.0002843687,0.001473652,0.0001103764,0.01491733],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9729109,"threshold_uncertainty_score":0.9998332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04381395519450773,"score_gpt":0.3065541168466964,"score_spread":0.2627401616521886,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}